A collaborative comparison of international pediatric diabetes registries.
benchmarking
diabetes mellitus
network
quality improvement
registry
Journal
Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
24
03
2022
received:
01
12
2021
accepted:
04
05
2022
pubmed:
14
5
2022
medline:
10
8
2022
entrez:
13
5
2022
Statut:
ppublish
Résumé
An estimated 1.1 million children and adolescents aged under 20 years have type 1 diabetes worldwide. Principal investigators from seven well-established longitudinal pediatric diabetes registries and the SWEET initiative have come together to provide an international collaborative perspective and comparison of the registries. Information and data including registry characteristics, pediatric participant clinical characteristics, data availability and data completeness from the Australasian Diabetes Data Network (ADDN), Danish Registry of Childhood and Adolescent Diabetes (DanDiabKids), Diabetes prospective follow-up registry (DPV), Norwegian Childhood Diabetes Registry (NCDR), National Paediatric Diabetes Audit (NPDA), Swedish Childhood Diabetes Registry (Swediabkids), T1D Exchange Quality Improvement Collaborative (T1DX-QI), and the SWEET initiative was extracted up until 31 December 2020. The seven diabetes registries and the SWEET initiative collectively show data of more than 900 centers and around 100,000 pediatric patients, the majority with type 1 diabetes. All share the common objectives of monitoring treatment and longitudinal outcomes, promoting quality improvement and equality in diabetes care and enabling clinical research. All generate regular benchmark reports. Main differences were observed in the definition of the pediatric population, the inclusion of adults, documentation of CGM metrics and collection of raw data files as well as linkage to other data sources. The open benchmarking and access to regularly updated data may prove to be the most important contribution from registries. This study describes aspects of the registries to enable future collaborations and to encourage the development of new registries where they do not exist.
Sections du résumé
BACKGROUND
An estimated 1.1 million children and adolescents aged under 20 years have type 1 diabetes worldwide. Principal investigators from seven well-established longitudinal pediatric diabetes registries and the SWEET initiative have come together to provide an international collaborative perspective and comparison of the registries.
WORK FLOW
Information and data including registry characteristics, pediatric participant clinical characteristics, data availability and data completeness from the Australasian Diabetes Data Network (ADDN), Danish Registry of Childhood and Adolescent Diabetes (DanDiabKids), Diabetes prospective follow-up registry (DPV), Norwegian Childhood Diabetes Registry (NCDR), National Paediatric Diabetes Audit (NPDA), Swedish Childhood Diabetes Registry (Swediabkids), T1D Exchange Quality Improvement Collaborative (T1DX-QI), and the SWEET initiative was extracted up until 31 December 2020.
REGISTRY OBJECTIVES AND OUTCOMES
The seven diabetes registries and the SWEET initiative collectively show data of more than 900 centers and around 100,000 pediatric patients, the majority with type 1 diabetes. All share the common objectives of monitoring treatment and longitudinal outcomes, promoting quality improvement and equality in diabetes care and enabling clinical research. All generate regular benchmark reports. Main differences were observed in the definition of the pediatric population, the inclusion of adults, documentation of CGM metrics and collection of raw data files as well as linkage to other data sources. The open benchmarking and access to regularly updated data may prove to be the most important contribution from registries. This study describes aspects of the registries to enable future collaborations and to encourage the development of new registries where they do not exist.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
627-640Informations de copyright
© 2022 The Authors. Pediatric Diabetes published by John Wiley & Sons Ltd.
Références
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
International Diabetes Federation. IDF Diabetes Atlas. 9th ed. International Diabetes Federation; 2019:2019.
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.
Krans H, Porta M, Keen H. Diabetes Care and Research in Europe: the Saint Vincent Declaration Action Program. WHO, regional office for Europe; 1992.
Bak JC, Serné EH, Kramer MH, Nieuwdorp M, Verheugt CL. National diabetes registries: do they make a difference? Acta Diabetol. 2021;58:267-278.
Gerhardsson P, Schwandt A, Witsch M, et al. The SWEET project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes. Diabetes Technol Ther. 2021;23:491-499.
Dabelea D, Mayer-Davis EJ, Imperatore G. The value of national diabetes registries: SEARCH for diabetes in youth study. Curr Diab Rep. 2010;10:362-369.
Danne T, Hanas R. The Mission of SWEET: harmonize care to optimize outcomes of children with diabetes worldwide. Pediatr Diabetes. 2016;17:3-6.
Clapin H, Phelan H, Bruns L Jr, et al. Australasian diabetes data network: building a collaborative resource. J Diabetes Sci Technol. 2016;10:1015-1026.
Svensson J, Cerqueira C, Kjaersgaard P, et al. Danish registry of childhood and adolescent diabetes. Clin Epidemiol. 2016;8:679-683.
Hofer SE, Schwandt A, Holl RW, Austrian/German DPV Initiative. Standardized documentation in pediatric diabetology: experience from Austria and Germany. J Diabetes Sci Technol. 2016;10:1042-1049.
Skrivarhaug T, Stene LC, Drivvoll AK, Strøm H, Joner G. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia. 2014;57:57-62.
Royal College of Paediatrics and Child Health. National Paediatric Diabetes Audit 2021. Royal College of Paediatrics and Child Health; 2021.
Samuelsson U. National Quality Registry for Diabetes in Children 0-18 Years. The Swedish National DIabetes Register (NDR); 2009.
Alonso GT, Corathers S, Shah A, et al. Establishment of the T1D exchange quality improvement collaborative (T1DX-QI). Clin Diabetes. 2020;38:141-151.
Prahalad P, Ebekozien O, Alonso GT, et al. Multi-clinic quality improvement initiative increases continuous glucose monitoring use among adolescents and young adults with type 1 diabetes. Clin Diabetes. 2021;39:264-271.
Majidi S, Ebekozien O, Noor N, et al. Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D exchange quality improvement collaborative. Clin Diabetes. 2021;39:278-283.
Lyons SK, Ebekozien O, Garrity A, et al. Increasing insulin pump use among 12-to 26-year-olds with type 1 diabetes: results from the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021;39:272-277.
Svensson J, Lyngaae-Jørgensen A, Carstensen B, Simonsen LB, Mortensen HB. Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes. 2009;10:248-254.
Royal College of Paediatrics and Child Health. National Paediatric Diabetes Audit Annual Report 2019-20: Care Processes and Outcomes. Royal College of Paediatrics and Child Health; 2021.
Saeed M, Tapia G, Ariansen I, et al. Serum Galectin-3 and subsequent risk of coronary heart disease in subjects with childhood-onset type 1 diabetes: a cohort study. Diabetes Care. 2021;44:810-816.
Nielsen NF, Gaulke A, Eriksen TM, Svensson J, Skipper N. Socioeconomic inequality in metabolic control among children with type 1 diabetes: a nationwide longitudinal study of 4,079 Danish children. Diabetes Care. 2019;42:1398-1405.
Sildorf SM, Breinegaard N, Lindkvist EB, et al. Poor metabolic control in children and adolescents with type 1 diabetes and psychiatric comorbidity. Diabetes Care. 2018;41:2289-2296.
Skrivarhaug T, Bangstad H, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2006;49:298-305.
Frøisland DH, Graue M, Markestad T, Skrivarhaug T, Wentzel-Larsen T, Dahl-Jørgensen K. Health-related quality of life among Norwegian children and adolescents with type 1 diabetes on intensive insulin treatment: a population-based study. Acta Paediatr (Oslo, Norway: 1992). 2013;102:889-895.
Garey CJ, Clements MA, McAuliffe-Fogarty AH, et al. The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes. Pediatr Diabetes. 2022;23:248-257.
Hodnekvam K, Iversen HH, Brunborg C, Skrivarhaug T. Development and validation of a questionnaire to assess young patients' experiences with diabetes care and transition. Acta Paediatr (Oslo, Norway: 1992). 2020;109:2057-2066.
Donaghue KC, Marcovecchio ML, Wadwa RP, et al. ISPAD clinical practice consensus guidelines 2018: microvascular and macrovascular complications in children and adolescents. Pediatric Diabetes, 2018;19:262-274.
Shachar C, Engel J, Elwyn G. Implications for telehealth in a postpandemic future: regulatory and privacy issues. JAMA. 2020;323:2375-2376.
Svensson J, Johannesen J, Mortensen HB, Nordly S, Danish Childhood Diabetes Registry. Improved metabolic outcome in a Danish diabetic paediatric population aged 0-18 yr: results from a nationwide continuous registration. Pediatr Diabetes. 2009;10:461-467.
Margeirsdottir HD, Larsen JR, Kummernes SJ, Brunborg C, Dahl-Jørgensen K. The establishment of a new national network leads to quality improvement in childhood diabetes: implementation of the ISPAD guidelines. Pediatr Diabetes. 2010;11:88-95.
Haynes A, Hermann JM, Clapin H, et al. Decreasing trends in mean HbA1c are not associated with increasing rates of severe hypoglycemia in children: a longitudinal analysis of two contemporary population-based pediatric type 1 diabetes registries from Australia and Germany/Austria between 1995 and 2016. Diabetes Care. 2019;42:1630-1636.
Charalampopoulos D, Hermann JM, Svensson J, et al. Exploring variation in glycemic control across and within eight high-income countries: a cross-sectional analysis of 64,666 children and adolescents with type 1 diabetes. Diabetes Care. 2018;41:1180-1187.
Cherubini V, Grimsmann JM, Åkesson K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia. 2020;63:1530-1541.
Sherr JL, Hermann JM, Campbell F, et al. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia. 2016;59:87-91.
Hanberger L, Birkebaek N, Bjarnason R, et al. Childhood diabetes in the Nordic countries: a comparison of quality registries. J Diabetes Sci Technol. 2014;8:738-744.
Anderzén J, Hermann JM, Samuelsson U, et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-a quality registry study. Pediatr Diabetes. 2020;21:621-627.
De Beaufort CE, Swift PG, Skinner CT, et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome?: the Hvidoere Study Group on childhood diabetes. Diabetes Care. 2007;30:2245-2250.
Arffman M, Ilanne-Parikka P, Keskimäki I, et al. FinDM database on diabetes in Finland. Finnish Institute for Health and Welfare (THL); 2020.
SCI-Diabetes. Scottish Care Information - Diabetes collaboration. The Scottish Care Information - Diabetes Collaboration (SCI-DC); 2021.
Hanberger L, Samuelsson U, Berterö C, Ludvigsson J. The influence of structure, process, and policy on HbA1c levels in treatment of children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2012;96:331-338.
Birkebaek NH, Hermann JM, Hanberger L, et al. Center size and glycemic control: an international study with 504 centers from seven countries. Diabetes Care. 2019;42:e37-e39.
Sildorf SM, Hertel NT, Thomsen J, et al. Treatment intensification without improved HbA1c levels in children and adolescents with type 1 diabetes mellitus. Diabet Med. 2016;33:515-522.
Hardin AP, Hackell JM. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine. Age limit of pediatrics. Pediatrics. 2017;140(3):e20172151.
Bohn B, Karges B, Vogel C, et al. 20 years of pediatric benchmarking in Germany and Austria: age-dependent analysis of longitudinal follow-up in 63,967 children and adolescents with type 1 diabetes. PLoS One. 2016;11:e0160971.
American Diabetes Association. 7. Diabetes technology: standards of medical care in diabetes-2021. Diabetes Care. 2021;44:S85-S99.
Sherr JL, Tauschmann M, Battelino T, et al. ISPAD clinical practice consensus guidelines 2018: diabetes technologies. Pediatr Diabetes. 2018;19:302-325.
Biester T, Grimsmann JM, Heidtmann B, et al. Intermittently scanned glucose values for continuous monitoring: cross-sectional analysis of glycemic control and hypoglycemia in 1809 children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2021;23:160-167.
Bratke H, Margeirsdottir HD, Assmus J, Njølstad PR, Skrivarhaug T. Does current diabetes technology improve metabolic control? A cross-sectional study on the use of insulin pumps and continuous glucose monitoring devices in a nationwide pediatric population. Diabetes Ther. 2021;12:1-13.
Skipper N, Thingholm PR, Borch L, et al. Center differences in diabetes treatment outcomes among children with type 1 diabetes: a nationwide study of 3866 Danish children. Pediatr Diabetes. 2022;23:73-83.
Skipper N, Gaulke A, Sildorf SM, Eriksen TM, Nielsen NF, Svensson J. Association of type 1 diabetes with standardized test scores of Danish schoolchildren. JAMA. 2019;321:484-492.
French R, Warner JT, Robinson H, et al. Educational Attainment and Childhood Onset Type 1 Diabetes: Evidence Against a Biological Link. Vol 3696832. SSRN; 2020.
Butwicka A, Frisén L, Almqvist C, Zethelius B, Lichtenstein P. Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study. Diabetes Care. 2015;38:453-459.